Radient Pharmaceuticals Announces Dedicated Onko-Sure Web Site
Radient Pharmaceuticals Corp (RPC) has launched a new interactive Web site for its USFDA-approved Onko-Sure in vitro diagnostic (IVD) cancer test.
Read MoreSearch Results for: lung cancer
Technologies Continue to Push Forward
This month’s cover story on mass spectrometry for the clinical lab is the first CLP has published on this topic, but I don’t believe it will be our last. According to sources at the FDA and the National Cancer Institute’s proteomics prog
Read More
Mass Spectrometry: An Emerging Path for Clinical Diagnostics
As diagnostics come to depend on increasingly sophisticated knowledge of biomarkers, mass spec emerges as a tool with revolutionary potential.
Read MoreProvista Validates Radient Pharmaceuticals’ Onko-Sure Test
Radient Pharmaceuticals Corp announced diagnostics development and commercialization firm Provista Life Sciences LLC (PLS) has independently validated Radient Pharmaceuticals’ Onko-Sure in vitro diagnostic (IVD) cancer test.
Read More
One and Only
Personalized medicine is not perfect, but it is personal. CLP looks at some new tests on the market to see how personal they are.
Read More